nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—respiratory system—lung cancer	0.0111	0.253	CbGeAlD
Tranexamic Acid—PLG—epithelium—lung cancer	0.00925	0.211	CbGeAlD
Tranexamic Acid—PLG—lung—lung cancer	0.00587	0.134	CbGeAlD
Tranexamic Acid—SLC15A2—mammary gland—lung cancer	0.00531	0.121	CbGeAlD
Tranexamic Acid—SLC15A2—respiratory system—lung cancer	0.00354	0.0809	CbGeAlD
Tranexamic Acid—SLC15A2—bronchus—lung cancer	0.00291	0.0666	CbGeAlD
Tranexamic Acid—SLC15A2—trachea—lung cancer	0.00261	0.0598	CbGeAlD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—MMP9—lung cancer	0.00236	0.00639	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP9—lung cancer	0.00236	0.00639	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—MMP9—lung cancer	0.00236	0.00639	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—SDC4—lung cancer	0.00231	0.00625	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—CD9—lung cancer	0.00228	0.00617	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00227	0.00616	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—CAT—lung cancer	0.00225	0.00609	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MMP2—lung cancer	0.0022	0.00595	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—APOA1—lung cancer	0.00218	0.00589	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SOD2—lung cancer	0.00213	0.00578	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—ALB—lung cancer	0.00212	0.00574	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00202	0.00548	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ADAMTS1—lung cancer	0.00198	0.00535	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—ADCY1—lung cancer	0.00196	0.00531	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—lung cancer	0.0019	0.00514	CbGpPWpGaD
Tranexamic Acid—SLC15A2—lung—lung cancer	0.00188	0.043	CbGeAlD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—GNG11—lung cancer	0.00187	0.00506	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—APOA1—lung cancer	0.00187	0.00505	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PPIA—lung cancer	0.00179	0.00485	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP1—lung cancer	0.00179	0.00485	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFC—lung cancer	0.00178	0.00481	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ALDOA—lung cancer	0.00178	0.00481	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—APOA1—lung cancer	0.00178	0.00481	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—lung cancer	0.00175	0.00474	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—APOA1—lung cancer	0.00173	0.00468	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—ALB—lung cancer	0.00172	0.00467	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.00172	0.00467	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—EIF2B4—lung cancer	0.00171	0.00463	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—KIF5B—lung cancer	0.00171	0.00462	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—EGF—lung cancer	0.00168	0.00456	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—lung cancer	0.00165	0.00446	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FGF9—lung cancer	0.00161	0.00436	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—EGF—lung cancer	0.0016	0.00434	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TF—lung cancer	0.00156	0.00423	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—lung cancer	0.00153	0.00415	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00153	0.00415	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—ALB—lung cancer	0.00148	0.004	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—IL6—lung cancer	0.00147	0.00397	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—NCAM1—lung cancer	0.00146	0.00394	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CDH1—lung cancer	0.00144	0.0039	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—ALB—lung cancer	0.00141	0.00381	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK3—lung cancer	0.0014	0.0038	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—KDM1A—lung cancer	0.0014	0.00379	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL2—lung cancer	0.0014	0.00378	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—KHSRP—lung cancer	0.00139	0.00377	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—APP—lung cancer	0.00139	0.00377	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP2—lung cancer	0.00139	0.00375	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—ALB—lung cancer	0.00137	0.00371	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—CASP3—lung cancer	0.00135	0.00366	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FOXO3—lung cancer	0.00135	0.00365	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—KIF5B—lung cancer	0.00134	0.00363	CbGpPWpGaD
Tranexamic Acid—SLC15A2—lymph node—lung cancer	0.00129	0.0294	CbGeAlD
Tranexamic Acid—PLG—Orphan transporters—CREBBP—lung cancer	0.00128	0.00347	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—EIF2B5—lung cancer	0.00122	0.0033	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PTGS2—lung cancer	0.0012	0.00324	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CD9—lung cancer	0.00117	0.00318	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—lung cancer	0.00116	0.00314	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00116	0.00313	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CASP3—lung cancer	0.0011	0.00298	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB3—lung cancer	0.00109	0.00296	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP9—lung cancer	0.00104	0.00282	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—ST3GAL5—lung cancer	0.00104	0.00281	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—lung cancer	0.00102	0.00276	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—FGR—lung cancer	0.00102	0.00276	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FGFR1—lung cancer	0.00102	0.00275	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL6—lung cancer	0.00101	0.00273	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—lung cancer	0.00097	0.00263	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ITGB1—lung cancer	0.000965	0.00261	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—GNG11—lung cancer	0.000962	0.00261	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—AKT1—lung cancer	0.000946	0.00256	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PPIA—lung cancer	0.000924	0.0025	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—ADAMTS1—lung cancer	0.000923	0.0025	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—B4GALT5—lung cancer	0.000923	0.0025	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000919	0.00249	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VEGFC—lung cancer	0.000916	0.00248	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ALDOA—lung cancer	0.000916	0.00248	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TP53—lung cancer	0.000898	0.00243	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—PIK3CA—lung cancer	0.000895	0.00242	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KIT—lung cancer	0.000882	0.00239	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000876	0.00237	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGF—lung cancer	0.000872	0.00236	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—TP53—lung cancer	0.000866	0.00235	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PPP2R1B—lung cancer	0.000843	0.00228	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—GNG11—lung cancer	0.000833	0.00226	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—APOA1—lung cancer	0.000827	0.00224	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL6—lung cancer	0.000822	0.00222	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—IL6R—lung cancer	0.000819	0.00222	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—GRP—lung cancer	0.000809	0.00219	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TF—lung cancer	0.000805	0.00218	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IRF1—lung cancer	0.000787	0.00213	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MAP2K1—lung cancer	0.000781	0.00211	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CD—lung cancer	0.000776	0.0021	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CG—lung cancer	0.000755	0.00204	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP1—lung cancer	0.00075	0.00203	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000749	0.00203	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000749	0.00203	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—EGF—lung cancer	0.000747	0.00202	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—AKT1—lung cancer	0.000731	0.00198	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—APP—lung cancer	0.000717	0.00194	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—KDR—lung cancer	0.000711	0.00193	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—ATF3—lung cancer	0.000705	0.00191	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—TF—lung cancer	0.000696	0.00189	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MDM2—lung cancer	0.000695	0.00188	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—RAF1—lung cancer	0.000692	0.00187	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB2—lung cancer	0.000685	0.00185	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CB—lung cancer	0.000676	0.00183	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MTOR—lung cancer	0.000676	0.00183	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CD—lung cancer	0.000664	0.0018	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AXL—lung cancer	0.000657	0.00178	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ALB—lung cancer	0.000655	0.00177	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—lung cancer	0.000653	0.00177	CbGpPWpGaD
Tranexamic Acid—Anaemia—Cisplatin—lung cancer	0.000644	0.0011	CcSEcCtD
Tranexamic Acid—Arrhythmia—Paclitaxel—lung cancer	0.000643	0.0011	CcSEcCtD
Tranexamic Acid—Asthenia—Topotecan—lung cancer	0.000637	0.00109	CcSEcCtD
Tranexamic Acid—Myalgia—Gemcitabine—lung cancer	0.000637	0.00109	CcSEcCtD
Tranexamic Acid—Arthralgia—Gemcitabine—lung cancer	0.000637	0.00109	CcSEcCtD
Tranexamic Acid—Chest pain—Gemcitabine—lung cancer	0.000637	0.00109	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—LMNA—lung cancer	0.000633	0.00171	CbGpPWpGaD
Tranexamic Acid—Asthenia—Erlotinib—lung cancer	0.000631	0.00107	CcSEcCtD
Tranexamic Acid—Discomfort—Gemcitabine—lung cancer	0.000629	0.00107	CcSEcCtD
Tranexamic Acid—Malaise—Cisplatin—lung cancer	0.000629	0.00107	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Irinotecan—lung cancer	0.000627	0.00107	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Vinorelbine—lung cancer	0.000626	0.00107	CcSEcCtD
Tranexamic Acid—Diarrhoea—Vinblastine—lung cancer	0.000626	0.00107	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Vinorelbine—lung cancer	0.000621	0.00106	CcSEcCtD
Tranexamic Acid—Back pain—Etoposide—lung cancer	0.000618	0.00105	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Irinotecan—lung cancer	0.000615	0.00105	CcSEcCtD
Tranexamic Acid—Muscle spasms—Etoposide—lung cancer	0.000614	0.00105	CcSEcCtD
Tranexamic Acid—Haemoglobin—Docetaxel—lung cancer	0.000613	0.00104	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Gemcitabine—lung cancer	0.000611	0.00104	CcSEcCtD
Tranexamic Acid—Haemorrhage—Docetaxel—lung cancer	0.00061	0.00104	CcSEcCtD
Tranexamic Acid—Diarrhoea—Topotecan—lung cancer	0.000608	0.00104	CcSEcCtD
Tranexamic Acid—Back pain—Paclitaxel—lung cancer	0.000606	0.00103	CcSEcCtD
Tranexamic Acid—Dizziness—Vinblastine—lung cancer	0.000605	0.00103	CcSEcCtD
Tranexamic Acid—Convulsion—Cisplatin—lung cancer	0.000604	0.00103	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—CDH1—lung cancer	0.000603	0.00163	CbGpPWpGaD
Tranexamic Acid—Muscle spasms—Paclitaxel—lung cancer	0.000602	0.00103	CcSEcCtD
Tranexamic Acid—Diarrhoea—Erlotinib—lung cancer	0.000601	0.00102	CcSEcCtD
Tranexamic Acid—Abdominal pain—Vinorelbine—lung cancer	0.000601	0.00102	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Gemcitabine—lung cancer	0.000599	0.00102	CcSEcCtD
Tranexamic Acid—Myalgia—Cisplatin—lung cancer	0.000594	0.00101	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—RAF1—lung cancer	0.000593	0.0016	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Etoposide—lung cancer	0.000593	0.00101	CcSEcCtD
Tranexamic Acid—Anaemia—Etoposide—lung cancer	0.00059	0.00101	CcSEcCtD
Tranexamic Acid—Visual impairment—Docetaxel—lung cancer	0.000588	0.001	CcSEcCtD
Tranexamic Acid—Dizziness—Topotecan—lung cancer	0.000587	0.001	CcSEcCtD
Tranexamic Acid—Discomfort—Cisplatin—lung cancer	0.000586	0.000999	CcSEcCtD
Tranexamic Acid—Hypotension—Irinotecan—lung cancer	0.000586	0.000998	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1A—lung cancer	0.000585	0.00159	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PTEN—lung cancer	0.000584	0.00158	CbGpPWpGaD
Tranexamic Acid—Vomiting—Vinblastine—lung cancer	0.000581	0.000991	CcSEcCtD
Tranexamic Acid—Dizziness—Erlotinib—lung cancer	0.000581	0.00099	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Paclitaxel—lung cancer	0.000581	0.00099	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP2—lung cancer	0.000581	0.00157	CbGpPWpGaD
Tranexamic Acid—Anaemia—Paclitaxel—lung cancer	0.000579	0.000986	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	0.000579	0.00157	CbGpPWpGaD
Tranexamic Acid—Malaise—Etoposide—lung cancer	0.000576	0.000981	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—ITGB1—lung cancer	0.000573	0.00155	CbGpPWpGaD
Tranexamic Acid—Headache—Vinblastine—lung cancer	0.000573	0.000976	CcSEcCtD
Tranexamic Acid—Hypotension—Gemcitabine—lung cancer	0.00057	0.000972	CcSEcCtD
Tranexamic Acid—Eye disorder—Docetaxel—lung cancer	0.00057	0.000971	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Cisplatin—lung cancer	0.000569	0.00097	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000568	0.000968	CcSEcCtD
Tranexamic Acid—Flushing—Docetaxel—lung cancer	0.000566	0.000964	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Docetaxel—lung cancer	0.000566	0.000964	CcSEcCtD
Tranexamic Acid—Vomiting—Topotecan—lung cancer	0.000565	0.000962	CcSEcCtD
Tranexamic Acid—Malaise—Paclitaxel—lung cancer	0.000565	0.000962	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Etoposide—lung cancer	0.000561	0.000957	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Doxorubicin—lung cancer	0.000561	0.000957	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Vinorelbine—lung cancer	0.00056	0.000954	CcSEcCtD
Tranexamic Acid—Vomiting—Erlotinib—lung cancer	0.000559	0.000952	CcSEcCtD
Tranexamic Acid—Dyspnoea—Irinotecan—lung cancer	0.000559	0.000952	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Cisplatin—lung cancer	0.000558	0.000951	CcSEcCtD
Tranexamic Acid—Headache—Topotecan—lung cancer	0.000557	0.000948	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000556	0.000948	CcSEcCtD
Tranexamic Acid—Convulsion—Etoposide—lung cancer	0.000553	0.000943	CcSEcCtD
Tranexamic Acid—Angiopathy—Docetaxel—lung cancer	0.000553	0.000943	CcSEcCtD
Tranexamic Acid—Dyspepsia—Irinotecan—lung cancer	0.000552	0.00094	CcSEcCtD
Tranexamic Acid—Immune system disorder—Docetaxel—lung cancer	0.000551	0.000938	CcSEcCtD
Tranexamic Acid—Headache—Erlotinib—lung cancer	0.000551	0.000938	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Paclitaxel—lung cancer	0.00055	0.000938	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Docetaxel—lung cancer	0.00055	0.000936	CcSEcCtD
Tranexamic Acid—Asthenia—Vinorelbine—lung cancer	0.000545	0.000929	CcSEcCtD
Tranexamic Acid—Arrhythmia—Docetaxel—lung cancer	0.000545	0.000928	CcSEcCtD
Tranexamic Acid—Dyspnoea—Gemcitabine—lung cancer	0.000544	0.000927	CcSEcCtD
Tranexamic Acid—Chest pain—Etoposide—lung cancer	0.000544	0.000927	CcSEcCtD
Tranexamic Acid—Nausea—Vinblastine—lung cancer	0.000543	0.000925	CcSEcCtD
Tranexamic Acid—Convulsion—Paclitaxel—lung cancer	0.000543	0.000925	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—AVP—lung cancer	0.000542	0.00147	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—SRC—lung cancer	0.000542	0.00147	CbGpPWpGaD
Tranexamic Acid—Migraine—Doxorubicin—lung cancer	0.000541	0.000923	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Irinotecan—lung cancer	0.000541	0.000922	CcSEcCtD
Tranexamic Acid—Fatigue—Irinotecan—lung cancer	0.00054	0.000921	CcSEcCtD
Tranexamic Acid—Discomfort—Etoposide—lung cancer	0.000537	0.000915	CcSEcCtD
Tranexamic Acid—Arthralgia—Paclitaxel—lung cancer	0.000533	0.000908	CcSEcCtD
Tranexamic Acid—Myalgia—Paclitaxel—lung cancer	0.000533	0.000908	CcSEcCtD
Tranexamic Acid—Chest pain—Paclitaxel—lung cancer	0.000533	0.000908	CcSEcCtD
Tranexamic Acid—Hypotension—Cisplatin—lung cancer	0.000532	0.000906	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IL2—lung cancer	0.000532	0.00144	CbGpPWpGaD
Tranexamic Acid—Nausea—Topotecan—lung cancer	0.000528	0.000899	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000527	0.000898	CcSEcCtD
Tranexamic Acid—Discomfort—Paclitaxel—lung cancer	0.000527	0.000898	CcSEcCtD
Tranexamic Acid—Abdominal discomfort—Methotrexate—lung cancer	0.000526	0.000897	CcSEcCtD
Tranexamic Acid—Fatigue—Gemcitabine—lung cancer	0.000526	0.000897	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000525	0.00142	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—STAT3—lung cancer	0.000522	0.00141	CbGpPWpGaD
Tranexamic Acid—Nausea—Erlotinib—lung cancer	0.000522	0.00089	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Etoposide—lung cancer	0.000521	0.000888	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—NRAS—lung cancer	0.000521	0.00141	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Vinorelbine—lung cancer	0.00052	0.000886	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000518	0.000883	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Irinotecan—lung cancer	0.000516	0.00088	CcSEcCtD
Tranexamic Acid—Back pain—Docetaxel—lung cancer	0.000513	0.000875	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Irinotecan—lung cancer	0.000512	0.000873	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Paclitaxel—lung cancer	0.000511	0.000871	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—COL4A2—lung cancer	0.000511	0.00138	CbGpPWpGaD
Tranexamic Acid—Muscle spasms—Docetaxel—lung cancer	0.00051	0.00087	CcSEcCtD
Tranexamic Acid—Dyspnoea—Cisplatin—lung cancer	0.000507	0.000864	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Gemcitabine—lung cancer	0.000503	0.000857	CcSEcCtD
Tranexamic Acid—Dizziness—Vinorelbine—lung cancer	0.000503	0.000856	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Paclitaxel—lung cancer	0.000501	0.000854	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK3—lung cancer	0.000499	0.00135	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GIPR—lung cancer	0.000498	0.00135	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Irinotecan—lung cancer	0.000495	0.000844	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Cisplatin—lung cancer	0.000491	0.000837	CcSEcCtD
Tranexamic Acid—Anaemia—Docetaxel—lung cancer	0.000491	0.000836	CcSEcCtD
Tranexamic Acid—Hypotension—Etoposide—lung cancer	0.000487	0.00083	CcSEcCtD
Tranexamic Acid—Vomiting—Vinorelbine—lung cancer	0.000483	0.000823	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—AVP—lung cancer	0.000483	0.00131	CbGpPWpGaD
Tranexamic Acid—Renal failure—Methotrexate—lung cancer	0.000481	0.00082	CcSEcCtD
Tranexamic Acid—Hypotension—Paclitaxel—lung cancer	0.000478	0.000814	CcSEcCtD
Tranexamic Acid—Headache—Vinorelbine—lung cancer	0.000476	0.000811	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000476	0.00129	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGFR—lung cancer	0.000475	0.00129	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Cisplatin—lung cancer	0.000469	0.000799	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000468	0.00127	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Docetaxel—lung cancer	0.000467	0.000795	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000466	0.000793	CcSEcCtD
Tranexamic Acid—Dyspnoea—Etoposide—lung cancer	0.000465	0.000792	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—SDC4—lung cancer	0.000465	0.00126	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SRC—lung cancer	0.000464	0.00126	CbGpPWpGaD
Tranexamic Acid—Angina pectoris—Doxorubicin—lung cancer	0.000463	0.000789	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—CASP3—lung cancer	0.000462	0.00125	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Irinotecan—lung cancer	0.000462	0.000787	CcSEcCtD
Tranexamic Acid—Convulsion—Docetaxel—lung cancer	0.00046	0.000784	CcSEcCtD
Tranexamic Acid—Dyspnoea—Paclitaxel—lung cancer	0.000456	0.000776	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—DUSP3—lung cancer	0.000455	0.00123	CbGpPWpGaD
Tranexamic Acid—Chest pain—Docetaxel—lung cancer	0.000452	0.00077	CcSEcCtD
Tranexamic Acid—Myalgia—Docetaxel—lung cancer	0.000452	0.00077	CcSEcCtD
Tranexamic Acid—Arthralgia—Docetaxel—lung cancer	0.000452	0.00077	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—lung cancer	0.000452	0.00122	CbGpPWpGaD
Tranexamic Acid—Nausea—Vinorelbine—lung cancer	0.000451	0.000769	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Etoposide—lung cancer	0.00045	0.000767	CcSEcCtD
Tranexamic Acid—Dyspepsia—Paclitaxel—lung cancer	0.00045	0.000767	CcSEcCtD
Tranexamic Acid—Asthenia—Irinotecan—lung cancer	0.00045	0.000766	CcSEcCtD
Tranexamic Acid—Fatigue—Etoposide—lung cancer	0.000449	0.000766	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—KRAS—lung cancer	0.000449	0.00121	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RHEB—lung cancer	0.000447	0.00121	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MMP1—lung cancer	0.000446	0.00121	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Methotrexate—lung cancer	0.000442	0.000753	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000441	0.000752	CcSEcCtD
Tranexamic Acid—Fatigue—Paclitaxel—lung cancer	0.000441	0.000751	CcSEcCtD
Tranexamic Acid—Haemorrhage—Methotrexate—lung cancer	0.00044	0.000749	CcSEcCtD
Tranexamic Acid—Asthenia—Gemcitabine—lung cancer	0.000438	0.000746	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP9—lung cancer	0.000436	0.00118	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Docetaxel—lung cancer	0.000433	0.000738	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Etoposide—lung cancer	0.00043	0.000732	CcSEcCtD
Tranexamic Acid—Diarrhoea—Irinotecan—lung cancer	0.000429	0.000731	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000428	0.00116	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000428	0.00116	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK3—lung cancer	0.000427	0.00116	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—APOA1—lung cancer	0.000426	0.00115	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Etoposide—lung cancer	0.000426	0.000726	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Docetaxel—lung cancer	0.000425	0.000724	CcSEcCtD
Tranexamic Acid—Visual impairment—Methotrexate—lung cancer	0.000424	0.000722	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GRM8—lung cancer	0.000423	0.00115	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Paclitaxel—lung cancer	0.000421	0.000718	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Cisplatin—lung cancer	0.000419	0.000714	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Paclitaxel—lung cancer	0.000418	0.000712	CcSEcCtD
Tranexamic Acid—Diarrhoea—Gemcitabine—lung cancer	0.000418	0.000712	CcSEcCtD
Tranexamic Acid—Renal failure—Doxorubicin—lung cancer	0.000417	0.00071	CcSEcCtD
Tranexamic Acid—Dizziness—Irinotecan—lung cancer	0.000414	0.000706	CcSEcCtD
Tranexamic Acid—Abdominal pain—Etoposide—lung cancer	0.000412	0.000702	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CA—lung cancer	0.000412	0.00112	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Methotrexate—lung cancer	0.000411	0.0007	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—SKI—lung cancer	0.00041	0.00111	CbGpPWpGaD
Tranexamic Acid—Asthenia—Cisplatin—lung cancer	0.000408	0.000696	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Methotrexate—lung cancer	0.000408	0.000695	CcSEcCtD
Tranexamic Acid—Hypotension—Docetaxel—lung cancer	0.000405	0.00069	CcSEcCtD
Tranexamic Acid—Abdominal pain—Paclitaxel—lung cancer	0.000404	0.000688	CcSEcCtD
Tranexamic Acid—Angiopathy—Methotrexate—lung cancer	0.000399	0.000679	CcSEcCtD
Tranexamic Acid—Vomiting—Irinotecan—lung cancer	0.000398	0.000679	CcSEcCtD
Tranexamic Acid—Sinusitis—Doxorubicin—lung cancer	0.000398	0.000678	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—TF—lung cancer	0.000398	0.00108	CbGpPWpGaD
Tranexamic Acid—Immune system disorder—Methotrexate—lung cancer	0.000397	0.000676	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Methotrexate—lung cancer	0.000396	0.000675	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000395	0.000673	CcSEcCtD
Tranexamic Acid—Headache—Irinotecan—lung cancer	0.000393	0.000669	CcSEcCtD
Tranexamic Acid—Diarrhoea—Cisplatin—lung cancer	0.000389	0.000663	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CG—lung cancer	0.000389	0.00105	CbGpPWpGaD
Tranexamic Acid—Vomiting—Gemcitabine—lung cancer	0.000388	0.000661	CcSEcCtD
Tranexamic Acid—Dyspnoea—Docetaxel—lung cancer	0.000386	0.000658	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—EGF—lung cancer	0.000385	0.00104	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Etoposide—lung cancer	0.000384	0.000654	CcSEcCtD
Tranexamic Acid—Haemoglobin—Doxorubicin—lung cancer	0.000383	0.000652	CcSEcCtD
Tranexamic Acid—Headache—Gemcitabine—lung cancer	0.000382	0.000652	CcSEcCtD
Tranexamic Acid—Dyspepsia—Docetaxel—lung cancer	0.000381	0.00065	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—HRAS—lung cancer	0.000381	0.00103	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Doxorubicin—lung cancer	0.000381	0.000648	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Paclitaxel—lung cancer	0.000377	0.000642	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Docetaxel—lung cancer	0.000374	0.000637	CcSEcCtD
Tranexamic Acid—Asthenia—Etoposide—lung cancer	0.000374	0.000637	CcSEcCtD
Tranexamic Acid—Fatigue—Docetaxel—lung cancer	0.000374	0.000636	CcSEcCtD
Tranexamic Acid—Nausea—Irinotecan—lung cancer	0.000372	0.000634	CcSEcCtD
Tranexamic Acid—Back pain—Methotrexate—lung cancer	0.00037	0.000631	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—APOA1—lung cancer	0.000369	0.000999	CbGpPWpGaD
Tranexamic Acid—Visual impairment—Doxorubicin—lung cancer	0.000367	0.000625	CcSEcCtD
Tranexamic Acid—Asthenia—Paclitaxel—lung cancer	0.000367	0.000625	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—lung cancer	0.000365	0.000988	CbGpPWpGaD
Tranexamic Acid—Nausea—Gemcitabine—lung cancer	0.000363	0.000618	CcSEcCtD
Tranexamic Acid—Vomiting—Cisplatin—lung cancer	0.000362	0.000616	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—CREBBP—lung cancer	0.000361	0.000977	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Docetaxel—lung cancer	0.000357	0.000608	CcSEcCtD
Tranexamic Acid—Diarrhoea—Etoposide—lung cancer	0.000357	0.000608	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PXN—lung cancer	0.000356	0.000964	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Doxorubicin—lung cancer	0.000356	0.000606	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Methotrexate—lung cancer	0.000355	0.000605	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Docetaxel—lung cancer	0.000354	0.000604	CcSEcCtD
Tranexamic Acid—Anaemia—Methotrexate—lung cancer	0.000354	0.000603	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Doxorubicin—lung cancer	0.000353	0.000602	CcSEcCtD
Tranexamic Acid—Flushing—Doxorubicin—lung cancer	0.000353	0.000602	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	0.000353	0.000955	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MMP1—lung cancer	0.000351	0.00095	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Paclitaxel—lung cancer	0.00035	0.000596	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—OXTR—lung cancer	0.000349	0.000944	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GRP—lung cancer	0.000349	0.000944	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKR1C1—lung cancer	0.000349	0.000944	CbGpPWpGaD
Tranexamic Acid—Angiopathy—Doxorubicin—lung cancer	0.000345	0.000588	CcSEcCtD
Tranexamic Acid—Malaise—Methotrexate—lung cancer	0.000345	0.000588	CcSEcCtD
Tranexamic Acid—Dizziness—Etoposide—lung cancer	0.000345	0.000587	CcSEcCtD
Tranexamic Acid—Immune system disorder—Doxorubicin—lung cancer	0.000344	0.000586	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Doxorubicin—lung cancer	0.000343	0.000584	CcSEcCtD
Tranexamic Acid—Abdominal pain—Docetaxel—lung cancer	0.000342	0.000584	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CD—lung cancer	0.000342	0.000927	CbGpPWpGaD
Tranexamic Acid—Arrhythmia—Doxorubicin—lung cancer	0.00034	0.000579	CcSEcCtD
Tranexamic Acid—Dizziness—Paclitaxel—lung cancer	0.000338	0.000576	CcSEcCtD
Tranexamic Acid—Nausea—Cisplatin—lung cancer	0.000338	0.000576	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—ALB—lung cancer	0.000338	0.000915	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—AKT1—lung cancer	0.000337	0.000911	CbGpPWpGaD
Tranexamic Acid—Convulsion—Methotrexate—lung cancer	0.000331	0.000565	CcSEcCtD
Tranexamic Acid—Vomiting—Etoposide—lung cancer	0.000331	0.000565	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—ALB—lung cancer	0.000329	0.000889	CbGpPWpGaD
Tranexamic Acid—Headache—Etoposide—lung cancer	0.000327	0.000556	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GNG11—lung cancer	0.000326	0.000883	CbGpPWpGaD
Tranexamic Acid—Myalgia—Methotrexate—lung cancer	0.000326	0.000555	CcSEcCtD
Tranexamic Acid—Chest pain—Methotrexate—lung cancer	0.000326	0.000555	CcSEcCtD
Tranexamic Acid—Arthralgia—Methotrexate—lung cancer	0.000326	0.000555	CcSEcCtD
Tranexamic Acid—Vomiting—Paclitaxel—lung cancer	0.000325	0.000554	CcSEcCtD
Tranexamic Acid—Discomfort—Methotrexate—lung cancer	0.000322	0.000548	CcSEcCtD
Tranexamic Acid—Back pain—Doxorubicin—lung cancer	0.00032	0.000546	CcSEcCtD
Tranexamic Acid—Headache—Paclitaxel—lung cancer	0.00032	0.000546	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Docetaxel—lung cancer	0.000319	0.000544	CcSEcCtD
Tranexamic Acid—Muscle spasms—Doxorubicin—lung cancer	0.000319	0.000543	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000312	0.000846	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Methotrexate—lung cancer	0.000312	0.000532	CcSEcCtD
Tranexamic Acid—Asthenia—Docetaxel—lung cancer	0.000311	0.00053	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—VEGFC—lung cancer	0.000311	0.000841	CbGpPWpGaD
Tranexamic Acid—Nausea—Etoposide—lung cancer	0.00031	0.000528	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Doxorubicin—lung cancer	0.000307	0.000524	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Methotrexate—lung cancer	0.000306	0.000522	CcSEcCtD
Tranexamic Acid—Anaemia—Doxorubicin—lung cancer	0.000306	0.000522	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—RAF1—lung cancer	0.000306	0.000827	CbGpPWpGaD
Tranexamic Acid—Nausea—Paclitaxel—lung cancer	0.000304	0.000517	CcSEcCtD
Tranexamic Acid—Malaise—Doxorubicin—lung cancer	0.000299	0.000509	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CB—lung cancer	0.000298	0.000808	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Docetaxel—lung cancer	0.000296	0.000505	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—ADCY1—lung cancer	0.000293	0.000794	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ALB—lung cancer	0.000292	0.000792	CbGpPWpGaD
Tranexamic Acid—Hypotension—Methotrexate—lung cancer	0.000292	0.000497	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—POMC—lung cancer	0.000292	0.000789	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Doxorubicin—lung cancer	0.000291	0.000496	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—lung cancer	0.000288	0.00078	CbGpPWpGaD
Tranexamic Acid—Convulsion—Doxorubicin—lung cancer	0.000287	0.000489	CcSEcCtD
Tranexamic Acid—Dizziness—Docetaxel—lung cancer	0.000286	0.000488	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PPP2R1B—lung cancer	0.000286	0.000774	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SMARCA4—lung cancer	0.000286	0.000774	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000284	0.000485	CcSEcCtD
Tranexamic Acid—Myalgia—Doxorubicin—lung cancer	0.000282	0.000481	CcSEcCtD
Tranexamic Acid—Arthralgia—Doxorubicin—lung cancer	0.000282	0.000481	CcSEcCtD
Tranexamic Acid—Chest pain—Doxorubicin—lung cancer	0.000282	0.000481	CcSEcCtD
Tranexamic Acid—Discomfort—Doxorubicin—lung cancer	0.000279	0.000475	CcSEcCtD
Tranexamic Acid—Dyspnoea—Methotrexate—lung cancer	0.000278	0.000474	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HSPB1—lung cancer	0.000276	0.000747	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—AVP—lung cancer	0.000276	0.000746	CbGpPWpGaD
Tranexamic Acid—Vomiting—Docetaxel—lung cancer	0.000275	0.000469	CcSEcCtD
Tranexamic Acid—Dyspepsia—Methotrexate—lung cancer	0.000275	0.000468	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IL2—lung cancer	0.000274	0.000742	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTHLH—lung cancer	0.000273	0.000738	CbGpPWpGaD
Tranexamic Acid—Headache—Docetaxel—lung cancer	0.000271	0.000462	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—MMP2—lung cancer	0.000271	0.000735	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Doxorubicin—lung cancer	0.00027	0.000461	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Methotrexate—lung cancer	0.00027	0.000459	CcSEcCtD
Tranexamic Acid—Fatigue—Methotrexate—lung cancer	0.000269	0.000459	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000267	0.000723	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Doxorubicin—lung cancer	0.000265	0.000452	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—RAF1—lung cancer	0.000265	0.000716	CbGpPWpGaD
Tranexamic Acid—Nausea—Docetaxel—lung cancer	0.000257	0.000438	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Methotrexate—lung cancer	0.000257	0.000438	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—ANXA1—lung cancer	0.000256	0.000694	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Methotrexate—lung cancer	0.000255	0.000435	CcSEcCtD
Tranexamic Acid—Hypotension—Doxorubicin—lung cancer	0.000253	0.00043	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FLT1—lung cancer	0.000248	0.000672	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Methotrexate—lung cancer	0.000247	0.000421	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000246	0.00042	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—EP300—lung cancer	0.000246	0.000666	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH3—lung cancer	0.000243	0.000658	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APP—lung cancer	0.000243	0.000658	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGF9—lung cancer	0.000241	0.000653	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Doxorubicin—lung cancer	0.000241	0.000411	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—SRC—lung cancer	0.000239	0.000647	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Doxorubicin—lung cancer	0.000238	0.000406	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000233	0.000398	CcSEcCtD
Tranexamic Acid—Fatigue—Doxorubicin—lung cancer	0.000233	0.000397	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—VEGFA—lung cancer	0.000233	0.00063	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JUNB—lung cancer	0.00023	0.000623	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Methotrexate—lung cancer	0.00023	0.000392	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—NRAS—lung cancer	0.00023	0.000623	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CXCL8—lung cancer	0.000226	0.000611	CbGpPWpGaD
Tranexamic Acid—Asthenia—Methotrexate—lung cancer	0.000224	0.000382	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Doxorubicin—lung cancer	0.000223	0.00038	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Doxorubicin—lung cancer	0.000221	0.000377	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—MAPK3—lung cancer	0.00022	0.000596	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Doxorubicin—lung cancer	0.000214	0.000364	CcSEcCtD
Tranexamic Acid—Diarrhoea—Methotrexate—lung cancer	0.000214	0.000364	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—APOA1—lung cancer	0.000211	0.00057	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STK11—lung cancer	0.000209	0.000566	CbGpPWpGaD
Tranexamic Acid—Dizziness—Methotrexate—lung cancer	0.000206	0.000352	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FOXO3—lung cancer	0.000202	0.000546	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Doxorubicin—lung cancer	0.000199	0.000339	CcSEcCtD
Tranexamic Acid—Vomiting—Methotrexate—lung cancer	0.000199	0.000338	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—KRAS—lung cancer	0.000198	0.000536	CbGpPWpGaD
Tranexamic Acid—Headache—Methotrexate—lung cancer	0.000196	0.000333	CcSEcCtD
Tranexamic Acid—Asthenia—Doxorubicin—lung cancer	0.000194	0.000331	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—AVP—lung cancer	0.000189	0.000512	CbGpPWpGaD
Tranexamic Acid—Nausea—Methotrexate—lung cancer	0.000185	0.000316	CcSEcCtD
Tranexamic Acid—Diarrhoea—Doxorubicin—lung cancer	0.000185	0.000315	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—IGF1R—lung cancer	0.000182	0.000493	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CA—lung cancer	0.000182	0.000492	CbGpPWpGaD
Tranexamic Acid—Dizziness—Doxorubicin—lung cancer	0.000179	0.000305	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HES1—lung cancer	0.000179	0.000484	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000178	0.000483	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TP53—lung cancer	0.000176	0.000476	CbGpPWpGaD
Tranexamic Acid—Vomiting—Doxorubicin—lung cancer	0.000172	0.000293	CcSEcCtD
Tranexamic Acid—Headache—Doxorubicin—lung cancer	0.000169	0.000289	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—HRAS—lung cancer	0.000168	0.000456	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ALB—lung cancer	0.000167	0.000452	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB3—lung cancer	0.000163	0.000443	CbGpPWpGaD
Tranexamic Acid—Nausea—Doxorubicin—lung cancer	0.000161	0.000274	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—TERT—lung cancer	0.000157	0.000424	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGFR1—lung cancer	0.000152	0.000412	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—RAF1—lung cancer	0.000151	0.000409	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HIF1A—lung cancer	0.00015	0.000406	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT1—lung cancer	0.000149	0.000402	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOA1—lung cancer	0.000145	0.000391	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KDR—lung cancer	0.000143	0.000388	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CG—lung cancer	0.000132	0.000357	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APC—lung cancer	0.000132	0.000357	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KIT—lung cancer	0.000132	0.000357	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGF—lung cancer	0.00013	0.000353	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—POMC—lung cancer	0.000126	0.00034	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BRAF—lung cancer	0.000124	0.000336	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6R—lung cancer	0.000123	0.000332	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CREBBP—lung cancer	0.000122	0.000331	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAP2K1—lung cancer	0.000117	0.000316	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CD—lung cancer	0.000116	0.000314	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MDM2—lung cancer	0.000104	0.000281	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RAF1—lung cancer	0.000104	0.00028	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB2—lung cancer	0.000102	0.000277	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MTOR—lung cancer	0.000101	0.000274	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CB—lung cancer	0.000101	0.000274	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL8—lung cancer	9.72e-05	0.000263	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CASP3—lung cancer	9.3e-05	0.000252	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL2—lung cancer	9.29e-05	0.000251	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCND1—lung cancer	9.05e-05	0.000245	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JUN—lung cancer	9.04e-05	0.000245	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP9—lung cancer	8.79e-05	0.000238	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1A—lung cancer	8.76e-05	0.000237	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTEN—lung cancer	8.74e-05	0.000237	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EP300—lung cancer	8.33e-05	0.000226	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SRC—lung cancer	8.1e-05	0.000219	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—lung cancer	7.89e-05	0.000214	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT3—lung cancer	7.82e-05	0.000212	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NRAS—lung cancer	7.8e-05	0.000211	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK3—lung cancer	7.47e-05	0.000202	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYC—lung cancer	7.26e-05	0.000197	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGFR—lung cancer	7.1e-05	0.000192	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KRAS—lung cancer	6.71e-05	0.000182	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CA—lung cancer	6.17e-05	0.000167	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—lung cancer	5.96e-05	0.000161	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HRAS—lung cancer	5.7e-05	0.000154	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—lung cancer	5.46e-05	0.000148	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT1—lung cancer	5.04e-05	0.000136	CbGpPWpGaD
